GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the ...

The research collaboration, under which Septerna will receive more than $200 million in upfront and near-term fees, is the ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

New research published in the American Journal of Health-System Pharmacy suggests a possible link between the GLP-1 drug ...

This Week’s Wellness Wednesday, we’re taking a look at a topic that crosses everyone’s mind, weight loss. There are many ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

In the first part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, ...

While M&A activity slowed in the first quarter of 2025, including in life sciences, there have been plenty of noteworthy developments in the ...

Doctors generally have an easier time diagnosing type 1 diabetes in kids, who present with classic symptoms of excessive thirst, excessive urination, and weight loss. “Children often have a really ...

The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...

Popular diabetes and weight loss drugs like Ozempic and Wegovy do not increase the risk of depression, anxiety or suicidal ideation, a new study finds.In fact, ...

When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed ...